Dickstein, Y. Lellouche, J. Schwartz, D. Nutman, A. Rakovitsky, N. Benattar, Y.D. Altunin, S. Bernardo, M. Iossa, D. Durante-Mangoni, E. Antoniadou, A. Skiada, A. Deliolanis, I. Daikos, G.L. Daitch, V. Yahav, D. Leibovici, L. Rognås, V. Friberg, L.E. Mouton, J.W. Paul, M. Carmeli, Y. Benattar, Y.D. Dickstein, Y. Bitterman, R. Zayyad, H. Koppel, F. Zak-Doron, Y. Altunin, S. Andria, N. Neuberger, A. Stern, A. Petersiel, N. Raines, M. Karban, A. Yahav, D. Eliakim-Raz, N. Zusman, O. Elbaz, M. Atamna, H. Daitch, V. Babich, T. Carmeli, Y. Nutman, A. Adler, A. Levi, I. Daikos, G.L. Skiada, A. Deliolanis, I. Pavleas, I. Antoniadou, A. Kotsaki, A. Andini, R. Iossa, D. Bernardo, M. Cavezza, G. Bertolino, L. Giuffre, G. Giurazza, R. Cuccurullo, S. Galdo, M. Murino, P. Cristinziano, A. Corcione, A. Zampino, R. Pafundi, P.C. Mouton, J. Friberg, L. Kristoffersson, A. Theuretzbacher, U. the AIDA Study Group, Colistin resistance development following colistin-meropenem combination therapy versus colistin monotherapy in patients with infections caused by carbapenem-resistant organisms, Clinical Infectious Diseases, (71), 2599-2607, 2020, Oxford University Press, 1058-4838, 1537-6591